Table 4.

Less than twofold declined regulated lipid elements of patients with severe acute pneumonia (SAP), acute pulmonary embolism (APE), or acute exacerbation of chronic pulmonary diseases (AECPD) with statistical significance, as compared with healthy control (p < 0.05 or less)

SAP			APE			AECPD
Elements	Folds	pvalue	Elements	Folds	pvalue	Elements	Folds	pvalue
PS41:6	0.50	0.01	PA 16:0/20:1	0.50	0.03	PA 16:0/20:1	0.47	0.02
PA 16:0/20:1	0.48	0.02	PS41:6	0.49	0.02	PS41:6	0.46	0.01
PI 38:1	0.47	0.00	PA 16:0/18:3	0.48	0.04	PS 18:0/22:3	0.46	0.01
PG40:5	0.47	0.03	PG39:3	0.43	0.05	PS 20:3/22:6	0.45	0.02
PA 18:3/18:4	0.43	0.01	PA 17:0/13:0	0.41	0.04	PA 10:0/18:1	0.44	0.02
PG39:3	0.41	0.03	PA 15:1/24:0	0.39	0.03	PA 10:0/18:0	0.43	0.00
PG37:1	0.40	0.04	PS38:1	0.39	0.02	PA 18:3/18:4	0.41	0.02
PI 18:0/17:1	0.39	0.00	PG37:1	0.36	0.04	PA 16:1/18:3	0.38	0.02
PA 16:1/18:3	0.38	0.02	PA 18:0/20:5	0.35	0.02	PA 15:1/24:0	0.37	0.02
PA 18:4/19:1	0.38	0.04	PS40:1	0.32	0.04	PA 14:1/21:4	0.36	0.03
PA 19:0/22:5	0.37	0.04	PA 20:0/21:5	0.31	0.02	PA 18:4/19:1	0.35	0.03
PG40:6	0.33	0.00	PA 15:0/25:0	0.29	0.04	PA 19:0/22:5	0.33	0.03
PA 15:1/24:0	0.33	0.01	PA 14:0/24:5	0.18	0.04	PA 16:1/18:4	0.33	0.03
PA 14:1/21:4	0.32	0.02	PA 14:1/20:5	0.11	0.00	PA 16:0/18:3	0.32	0.01
PG40:8	0.31	0.00	PA 15:0/20:5	0.04	0.01	PA 17:0/13:0	0.30	0.01
PA 16:0/18:3	0.31	0.00				PA 19:0/23:0	0.29	0.03
PA 19:0/23:0	0.31	0.03				PA 20:0/21:5	0.25	0.01
PA 17:0/13:0	0.28	0.01				PA 15:0/25:0	0.22	0.02
PA 18:1/20:4	0.25	0.04				PA 14:1/20:5	0.10	0.00
PA 20:0/21:5	0.22	0.01				PA 15:0/20:5	0.06	0.00
PA 15:0/25:0	0.20	0.01
PA 14:1/20:5	0.08	0.00
PA 15:0/20:5	0.04	0.00